<VariationArchive VariationID="817385" VariationName="NM_000293.3(PHKB):c.2457del (p.Glu820fs)" VariationType="Deletion" Accession="VCV000817385" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-03-05" DateCreated="2020-03-16" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="805884" VariationID="817385">
      <GeneList>
        <Gene Symbol="PHKB" FullName="phosphorylase kinase regulatory subunit beta" GeneID="5257" HGNC_ID="HGNC:8927" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="47461299" stop="47701523" display_start="47461299" display_stop="47701523" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="47495209" stop="47735433" display_start="47495209" display_stop="47735433" Strand="+" />
          </Location>
          <OMIM>172490</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000293.3(PHKB):c.2457del (p.Glu820fs)</Name>
      <CanonicalSPDI>NC_000016.10:47669242:AA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q12.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="47669243" stop="47669243" display_start="47669243" display_stop="47669243" variantLength="1" positionVCF="47669242" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="47703154" stop="47703154" display_start="47703154" display_stop="47703154" variantLength="1" positionVCF="47703153" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>p.Glu820Lysfs*11</Name>
      </OtherNameList>
      <ProteinChange>E813fs</ProteinChange>
      <ProteinChange>E820fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.47669244del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.47669244del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.47703155del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.47703155del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016598.1" sequenceAccession="NG_016598" sequenceVersion="1" change="g.212946del">
            <Expression>NG_016598.1:g.212946del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000293.3" sequenceAccession="NM_000293" sequenceVersion="3" change="c.2457del" MANESelect="true">
            <Expression>NM_000293.3:c.2457del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000284.1" sequenceAccession="NP_000284" sequenceVersion="1" change="p.Glu820fs">
            <Expression>NP_000284.1:p.Glu820fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001031835.3" sequenceAccession="NM_001031835" sequenceVersion="3" change="c.2436del">
            <Expression>NM_001031835.3:c.2436del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001027005.1" sequenceAccession="NP_001027005" sequenceVersion="1" change="p.Glu813fs">
            <Expression>NP_001027005.1:p.Glu813fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363837.1" sequenceAccession="NM_001363837" sequenceVersion="1" change="c.2457del">
            <Expression>NM_001363837.1:c.2457del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350766.1" sequenceAccession="NP_001350766" sequenceVersion="1" change="p.Glu820fs">
            <Expression>NP_001350766.1:p.Glu820fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1322527832" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000293.3(PHKB):c.2457del (p.Glu820fs) AND not provided" Accession="RCV001008508" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-03-29" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000293.3(PHKB):c.2457del (p.Glu820fs) AND Glycogen storage disease IXb" Accession="RCV002549289" Version="2">
        <ClassifiedConditionList TraitSetID="3748">
          <ClassifiedCondition DB="MedGen" ID="C0543514">Glycogen storage disease IXb</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-23" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2020-03-16" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9215682</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9326319</ID>
        </Citation>
        <DescriptionHistory Dated="2024-01-05">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3748" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1937" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease IXb</ElementValue>
                <XRef ID="Glycogen+storage+disease+IXb/8483" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009868" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLYCOGENOSIS OF LIVER AND MUSCLE, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="261750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD IXb</ElementValue>
                <XRef Type="MIM" ID="261750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PHOSPHORYLASE KINASE DEFICIENCY OF LIVER AND MUSCLE, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="261750" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD9B</ElementValue>
                <XRef Type="MIM" ID="261750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Phosphorylase kinase (PhK) deficiency causing glycogen storage disease type IX (GSD IX) results from deficiency of the enzyme phosphorylase b kinase, which has a major regulatory role in the breakdown of glycogen. The two types of PhK deficiency are liver PhK deficiency (characterized by early childhood onset of hepatomegaly and growth restriction, and often, but not always, fasting ketosis and hypoglycemia) and muscle PhK deficiency, which is considerably rarer (characterized by any of the following: exercise intolerance, myalgia, muscle cramps, myoglobinuria, and progressive muscle weakness). While symptoms and biochemical abnormalities of liver PhK deficiency were thought to improve with age, it is becoming evident that affected individuals need to be monitored for long-term complications such as liver fibrosis and cirrhosis.</Attribute>
                <XRef ID="NBK55061" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16711" />
                <XRef ID="16711" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21634085</ID>
                <ID Source="BookShelf">NBK55061</ID>
              </Citation>
              <XRef ID="79240" DB="Orphanet" />
              <XRef ID="C0543514" DB="MedGen" />
              <XRef ID="MONDO:0009868" DB="MONDO" />
              <XRef Type="MIM" ID="261750" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2306273" SubmissionDate="2019-10-15" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDX:2653989|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001168280" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.2457delA variant in the PHKB gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.2457delA variant causes a frameshift starting with codon Glutamic Acid 820, changes this amino acid to a Lysine residue, and creates a premature Stop codon at position 11 of the new reading frame, denoted p.Glu820LysfsX11. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.2457delA variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.2457delA as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHKB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000293.2:c.2457delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7898146" SubmissionDate="2023-12-21" DateLastUpdated="2024-01-06" DateCreated="2024-01-06">
        <ClinVarSubmissionID localKey="1725656|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004226682" DateUpdated="2024-01-06" DateCreated="2024-01-06" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>PM2, PVS1</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHKB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000293.3:exon 26</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Glu820Lysfs*11</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000293.3:c.2457del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104855</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5710927" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="11059114|MedGen:C0543514" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003023139" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9215682</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9326319</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Glu820Lysfs*11) in the PHKB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PHKB are known to be pathogenic (PMID: 9215682, 9326319). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PHKB-related conditions. ClinVar contains an entry for this variant (Variation ID: 817385). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHKB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.47703154del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0543514" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5710927" TraitType="Disease" MappingType="XRef" MappingValue="C0543514" MappingRef="MedGen">
        <MedGen CUI="C0543514" Name="Glycogen storage disease IXb" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7898146" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2306273" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

